Clinical effects of allylestrenol on benign prostatic hypertrophy by double-blind method

Clinical effects of allylestrenol on benign prostatic hypertrophy by double-blind method

A double blind comparative clinical trial was performed with allylestrenol (AE) and chlormadinone acetate (CMA) to investigate the clinical efficacy of AE on prostatic hypertrophy. Both drugs were administered orally for 12-16 weeks in a daily dose of 50 mg. With both drugs marked improvement of dis...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Hinyokika kiyo. Acta urologica Japonica. - 1962. - 32(1986), 4 vom: 12. Apr., Seite 625-48
1. Verfasser: Shida, K (VerfasserIn)
Weitere Verfasser: Koyanagi, T, Kawakura, K, Nishida, T, Kumamoto, Y, Orikasa, S, Sato, S, Takeda, M, Yamanaka, H, Shimazaki, J
Format: Aufsatz
Sprache:Japanese
Veröffentlicht: 1986
Zugriff auf das übergeordnete Werk:Hinyokika kiyo. Acta urologica Japonica
Schlagworte:Clinical Trial Comparative Study Controlled Clinical Trial English Abstract Journal Article Estrenes Chlormadinone Acetate 0SY050L61N Allylestrenol I47VB5DZ8O